Payment overview · 2025
General Payments
$183.52
9 reported records · 3 companies
Healthcare provider profile · identity verified
Robert W West, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · EVANS, GA · NPI 1467555276
Verified facts
What the public records show
CMS Open Payments records show Robert W West, M.D. received $183.52 in general payments during 2025 across 9 reported records.
Novo Nordisk Inc accounted for 59.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 128 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $109.89 | 59.9% | 5 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $59.74 | 32.5% | 3 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $13.89 | 7.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $183.52 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $66.74 | 3 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $59.74 | 3 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $43.15 | 2 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $21.94 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $13.89 | 1 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $13.89 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 128 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
128 | 22 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1040 | 276 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1026 | 290 |
| Amlodipine Besylate | Amlodipine Besylate | 706 | 187 |
| Pantoprazole Sodium | Pantoprazole Sodium | 610 | 177 |
| Lisinopril | Lisinopril | 592 | 175 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 585 | 174 |
| Losartan Potassium | Losartan Potassium | 475 | 136 |
| Hydrochlorothiazide | Hydrochlorothiazide | 418 | 129 |
| Lorazepam | Lorazepam | 393 | 98 |
| Metformin Hcl Er | Metformin Hcl | 356 | 104 |
| Omeprazole | Omeprazole | 347 | 95 |
| Gabapentin | Gabapentin | 322 | 94 |
| Metoprolol Succinate | Metoprolol Succinate | 302 | 79 |
| Alprazolam | Alprazolam | 280 | 78 |
| Simvastatin | Simvastatin | 277 | 74 |
| Tamsulosin Hcl | Tamsulosin Hcl | 266 | 80 |
| Allopurinol | Allopurinol | 262 | 66 |
| Eliquis | Apixaban | 234 | 46 |
| Famotidine | Famotidine | 233 | 76 |
| Zolpidem Tartrate | Zolpidem Tartrate | 222 | 54 |
| Synthroid | Levothyroxine Sodium | 207 | 50 |
| Sertraline Hcl | Sertraline Hcl | 203 | 51 |
| Pravastatin Sodium | Pravastatin Sodium | 199 | 55 |
| Potassium Chloride | Potassium Chloride | 197 | 52 |
| Metformin Hcl | Metformin Hcl | 192 | 51 |
| Tramadol Hcl | Tramadol Hcl | 188 | 59 |
| Carvedilol | Carvedilol | 187 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 179 | 64 |
| Citalopram Hbr | Citalopram Hydrobromide | 171 | 46 |
| Trazodone Hcl | Trazodone Hcl | 168 | 51 |
| Meloxicam | Meloxicam | 161 | 56 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 156 | 42 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 153 | 41 |
| Montelukast Sodium | Montelukast Sodium | 149 | 37 |
| Clopidogrel | Clopidogrel Bisulfate | 148 | 44 |
| Bupropion Xl | Bupropion Hcl | 142 | 39 |
| Metoprolol Tartrate | Metoprolol Tartrate | 141 | 42 |
| Furosemide | Furosemide | 140 | 44 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 138 | 41 |
| Duloxetine Hcl | Duloxetine Hcl | 132 | 33 |
| Jardiance | Empagliflozin | 129 | 27 |
| Ozempic | Semaglutide | 128 | 22 |
| Januvia | Sitagliptin Phosphate | 119 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 117 | 43 |
| Clonazepam | Clonazepam | 114 | 24 |
| Atenolol | Atenolol | 113 | 29 |
| Mounjaro | Tirzepatide | 107 | 20 |
| Pregabalin | Pregabalin | 104 | 21 |
| Glimepiride | Glimepiride | 101 | 29 |
| Celecoxib | Celecoxib | 98 | 32 |
| Irbesartan | Irbesartan | 98 | 23 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 91 | 24 |
| Ezetimibe | Ezetimibe | 89 | 28 |
| Finasteride | Finasteride | 89 | 25 |
| Myrbetriq | Mirabegron | 84 | 17 |
| Estradiol | Estradiol | 82 | 29 |
| Telmisartan | Telmisartan | 81 | 24 |
| Spironolactone | Spironolactone | 75 | 18 |
| Diclofenac Sodium | Diclofenac Sodium | 73 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 73 | 21 |
| Primidone | Primidone | 73 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 71 | 17 |
| Donepezil Hcl | Donepezil Hcl | 69 | 22 |
| Diazepam | Diazepam | 68 | 23 |
| Testosterone Cypionate | Testosterone Cypionate | 66 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 65 | 54 |
| Pioglitazone Hcl | Pioglitazone Hcl | 65 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 64 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 62 | 19 |
| Trulicity | Dulaglutide | 62 | 11 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 60 | 18 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 60 | 20 |
| Prednisone | Prednisone | 60 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 58 | 25 |
| Ropinirole Hcl | Ropinirole Hcl | 58 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 57 | 18 |
| Torsemide | Torsemide | 57 | 14 |
| Fenofibrate | Fenofibrate Nanocrystallized | 56 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 55 | 18 |
| Xarelto | Rivaroxaban | 55 | 15 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 54 | 49 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 52 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 52 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 52 | 12 |
| Memantine Hcl | Memantine Hcl | 52 | 15 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 51 | 13 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 49 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 48 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 48 | 15 |
| Mirtazapine | Mirtazapine | 47 | 13 |
| Valacyclovir | Valacyclovir Hcl | 47 | 27 |
| Valsartan | Valsartan | 47 | 14 |
| Benazepril Hcl | Benazepril Hcl | 46 | 17 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 46 | 13 |
| Cefdinir | Cefdinir | 45 | 36 |
| Methylprednisolone | Methylprednisolone | 45 | 39 |
| Tizanidine Hcl | Tizanidine Hcl | 45 | 20 |
| Buspirone Hcl | Buspirone Hcl | 43 | 14 |
| Propranolol Hcl | Propranolol Hcl | 43 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 42 | 19 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 41 | 11 |
| Linzess | Linaclotide | 41 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 41 | 14 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 40 | 11 |
| Meclizine Hcl | Meclizine Hcl | 40 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 40 | suppressed |
| Temazepam | Temazepam | 40 | 12 |
| Testosterone | Testosterone | 40 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 39 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 39 | 29 |
| Topiramate | Topiramate | 37 | suppressed |
| Azithromycin | Azithromycin | 36 | 32 |
| Fenofibrate | Fenofibrate | 36 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 35 | 33 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 34 | suppressed |
| Fluconazole | Fluconazole | 33 | 19 |
| Glipizide Er | Glipizide | 33 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 33 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 32 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 32 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 31 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 31 | 12 |
| Ramipril | Ramipril | 31 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 21 |
| Klor-Con M20 | Potassium Chloride | 29 | 11 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 28 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 27 | suppressed |
| Bumetanide | Bumetanide | 27 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 24 |
| Lansoprazole | Lansoprazole | 27 | suppressed |
| Repatha Sureclick | Evolocumab | 27 | suppressed |
| Novolog Flexpen | Insulin Aspart | 26 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 26 | 26 |
| Eszopiclone | Eszopiclone | 25 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 25 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 25 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 24 | 15 |
| Methocarbamol | Methocarbamol | 24 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Colchicine | Colchicine | 23 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 23 | suppressed |
| Entresto | Sacubitril/Valsartan | 23 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 23 | 13 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Cephalexin | Cephalexin | 21 | 15 |
| Carisoprodol | Carisoprodol | 20 | suppressed |
| Glipizide | Glipizide | 20 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 20 | suppressed |
| Chlorthalidone | Chlorthalidone | 19 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 18 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Ketoconazole | Ketoconazole | 18 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Acyclovir | Acyclovir | 17 | suppressed |
| Nabumetone | Nabumetone | 17 | suppressed |
| Naproxen | Naproxen | 17 | suppressed |
| Niacin Er | Niacin | 17 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 16 | suppressed |
| Dutasteride | Dutasteride | 16 | suppressed |
| Folic Acid | Folic Acid | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | 12 |
| Promethazine Hcl | Promethazine Hcl | 16 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 12 |
| Theophylline Er | Theophylline Anhydrous | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 15 | suppressed |
| Humalog | Insulin Lispro | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | 11 |
| Carbamazepine Er | Carbamazepine | 14 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Lubiprostone | Lubiprostone | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 14 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 13 | 13 |
| Digoxin | Digoxin | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Paroxetine Cr | Paroxetine Hcl | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Clonidine | Clonidine | 11 | suppressed |
| Zaleplon | Zaleplon | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $183.52 · 9 records | Novo Nordisk Inc | Dexcom G6 Transmitter, EVENITY, Ozempic, PROLIA, Rybelsus, Wegovy | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error